158 related articles for article (PubMed ID: 37065565)
1. PTMA binds to HMGB1 to regulate mitochondrial oxidative phosphorylation and thus affect the malignant progression of esophageal squamous cell carcinoma.
Chen S; He R; Lin X; Zhang W; Chen H; Xu R; Kang M
J Thorac Dis; 2023 Mar; 15(3):1302-1318. PubMed ID: 37065565
[TBL] [Abstract][Full Text] [Related]
2. Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB).
Zhu Y; Qi X; Yu C; Yu S; Zhang C; Zhang Y; Liu X; Xu Y; Yang C; Jiang W; Tian G; Li X; Bergquist J; Zhang J; Wang L; Mi J
Clin Proteomics; 2019; 16():12. PubMed ID: 30988666
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma.
Di X; He G; Chen H; Zhu C; Qin Q; Yan J; Zhang X; Sun X
J Gastroenterol Hepatol; 2019 Apr; 34(4):728-735. PubMed ID: 29968320
[TBL] [Abstract][Full Text] [Related]
4. α-Hederin Induces Apoptosis of Esophageal Squamous Cell Carcinoma via an Oxidative and Mitochondrial-Dependent Pathway.
Wang J; Wu D; Zhang J; Liu H; Wu J; Dong W
Dig Dis Sci; 2019 Dec; 64(12):3528-3538. PubMed ID: 31273592
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circLPAR3 Facilitates Esophageal Squamous Cell Carcinoma Progression Through Upregulating HMGB1 via Sponging miR-375/miR-433.
Cheng H; Jiang W; Song Z; Li T; Li Y; Zhang L; Wang G
Onco Targets Ther; 2020; 13():7759-7771. PubMed ID: 32801782
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Intracellular and Extracellular High-Mobility Group Box-1 in the Progression of Esophageal Squamous Cell Carcinoma.
Matsubara D; Konishi H; Arita T; Shoda K; Fujita Y; Ogino S; Takao K; Nanishi K; Kosuga T; Komatsu S; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Ann Surg Oncol; 2020 Sep; 27(9):3233-3244. PubMed ID: 32221734
[TBL] [Abstract][Full Text] [Related]
7. Circ_0008726 promotes malignant progression of ESCC cells through miR-206/HOXA13 pathway.
Han T; Shi M; Chen G; Hao J
Gen Thorac Cardiovasc Surg; 2023 Jan; 71(1):33-45. PubMed ID: 36190650
[TBL] [Abstract][Full Text] [Related]
8. Verbascoside represses malignant phenotypes of esophageal squamous cell carcinoma cells by inhibiting CDC42 via the HMGB1/RAGE axis.
Ji M; Sun J; Zhao J
Hum Exp Toxicol; 2022; 41():9603271221127429. PubMed ID: 36112883
[TBL] [Abstract][Full Text] [Related]
9. SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain.
Liu Y; Xiong R; Xiao T; Xiong L; Wu J; Li J; Feng G; Song G; Liu K
BMC Cancer; 2022 Dec; 22(1):1304. PubMed ID: 36513999
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC.
Dong J; Zhang X; Du X; Zou N; Shen W; Ma M; Wang Y; Zhu S
J Cancer; 2022; 13(9):2717-2726. PubMed ID: 35812184
[TBL] [Abstract][Full Text] [Related]
11. PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels.
Chen S; Lin X; He R; Zhang W; Kang M; Xu R
Exp Cell Res; 2023 May; 426(2):113567. PubMed ID: 36965748
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma.
Li L; Beeraka NM; Xie L; Dong L; Liu J; Wang L
Discov Oncol; 2022 Jul; 13(1):64. PubMed ID: 35829833
[TBL] [Abstract][Full Text] [Related]
13. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Regulator KDM4D Restricts Tumorigenesis
Yao W; Wang J; Zhu L; Jia X; Xu L; Tian X; Hu S; Wu S; Wei L
Front Oncol; 2021; 11():761346. PubMed ID: 34820329
[TBL] [Abstract][Full Text] [Related]
15. The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Chuangui C; Peng T; Zhentao Y
Pathol Oncol Res; 2012 Oct; 18(4):1021-7. PubMed ID: 22544356
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor NFE2L3 promotes the proliferation of esophageal squamous cell carcinoma cells and causes radiotherapy resistance by regulating IL-6.
Chen T; Xu B; Chen H; Sun Y; Song J; Sun X; Zhang X; Hua W
Comput Methods Programs Biomed; 2022 Nov; 226():107102. PubMed ID: 36108571
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
Chen CG; Cui L; Tang P; Yu ZT
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
[TBL] [Abstract][Full Text] [Related]
18. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
[TBL] [Abstract][Full Text] [Related]
19. Irradiation-induced exosomal HMGB1 to confer radioresistance via the PI3K/AKT/FOXO3A signaling pathway in ESCC.
Du X; Zhang X; Dong J; Zou N; Guo D; Yao W; Wang X; Li S; Song C; Yan K; Shen W; Zhu S
J Transl Med; 2022 Nov; 20(1):507. PubMed ID: 36335371
[TBL] [Abstract][Full Text] [Related]
20. CircLPAR3 knockdown suppresses esophageal squamous cell carcinoma cell oncogenic phenotypes and Warburg effect through miR-873-5p/LDHA axis.
Cheng Y; Ma Z; Liu S; Yang X; Li S
Hum Exp Toxicol; 2022; 41():9603271221143695. PubMed ID: 36484173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
